Identification of two novel variants, c.–35A>T and c.[–35A>T, 725T>G], in the FUT1 gene in a patient exhibiting the para‐Bombay phenotype
Transfusion · 2024-12 · 64 (12) · 2252-2259
DOI: 10.1111/trf.18053 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, online erschienen am 29.10.2024. Verfasst von Kamphon Intharanut und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumtani, Thailand. Hauptthemen laut MEDLINE: ABO Blood-Group System, Fucosyltransferases, Galactoside 2-alpha-L-fucosyltransferase, Phenotype. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Reduced or absent H antigens on red cells with the (para‐)Bombay phenotype can arise from FUT1 gene mutations, impacting the structure and function of 1,2‐L‐fucosyltransferase 1 (1,2‐L‐FucT1). Here, we identified the novel mutations in one patient displaying the para‐Bombay phenotype and examined the potential molecular mechanisms underlying this phenotype. Materials and Methods ABH antigens and antibodies were detected in patient's blood and saliva using serological methods. The genotypes of ABO , FUT1 , and FUT2 were imputed using the genetic variations discovered in the whole exome sequencing data. Three‐dimensional (3D) models of FUT1 variants were built using Deepmind's AlphaFold2 and HDOCK, and the possible effects of the variants were predicted to evaluate using DynaMut2 and Polyphen‐2.
Results
Serological analysis confirmed the para‐Bombay B phenotype producing anti‐HI and exhibiting normal genotypes ABO*B.01 / O.01.02 and FUT2*01.09 / 01.09 . Remarkably, the phenotype is caused by a compound heterozygous genotype: one allele containing the novel c.–35A>T mutation and the known c.725T>G mutation (p.Leu242Arg) of FUT1 , and the other allele containing the c.–35A>T mutation. From the computerized stimulation analysis, p.Arg242 of the FUT1 variant may be detrimental, destabilizing, and probably damaging to 1,2‐L‐FucT1, although not altering the 3D structure of the entire enzyme. The c.–35A>T promoter DNA left at the binding interface of both ZID and c‐Rel transcription factors may enable regulation of 1,2‐L‐FucT1 function at gene promoters.
Conclusion
We identified the two novel variants, c.–35A>T and c.[−35A>T, 725T>G], in the FUT1 causing the para‐Bombay phenotype. This finding may clarify the molecular mechanisms and enhance blood transfusion safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumtani, Thailand.
- Blood Bank, Thammasat University Hospital, Pathumtani, Thailand.
- Center of Research Excellence in Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Kamphon Intharanut, Kantaphon Glab-Ampai, Oytip Nathalang
Zitieren
APA
Intharanut, K., Khumsuk, P., Chidtrakoon, S., Glab-Ampai, K., & Nathalang, O. (2024). Identification of two novel variants, c.–35A>T and c.[–35A>T, 725T>G], in the FUT1 gene in a patient exhibiting the para‐Bombay phenotype. Transfusion, 64(12), 2252-2259. https://doi.org/10.1111/trf.18053
Vancouver
Intharanut K, Khumsuk P, Chidtrakoon S, Glab-Ampai K, Nathalang O. Identification of two novel variants, c.–35A>T and c.[–35A>T, 725T>G], in the FUT1 gene in a patient exhibiting the para‐Bombay phenotype. Transfusion. 2024;64(12):2252-2259. doi:10.1111/trf.18053
BibTeX
@article{Intharanut2024,
author = {Intharanut, Kamphon and Khumsuk, Piyathida and Chidtrakoon, Sarisa and Glab-Ampai, Kantaphon and Nathalang, Oytip},
title = {Identification of two novel variants, c.–35A>T and c.[–35A>T, 725T>G], in the FUT1 gene in a patient exhibiting the para‐Bombay phenotype},
journal = {Transfusion},
year = {2024},
volume = {64},
number = {12},
pages = {2252--2259},
doi = {10.1111/trf.18053}
}
EUVIMED